Amanda Agyemang

  • New York, NY
  • Pediatric allergy/immunology physician
NPI1851718043
Part D claims, 2019
26
Publications
10
Industry payments
$323
Affiliated sites
1
Medical group
1
Practice address
1184 5th Ave, New York, NY 10029
Practice phone
Call (212) 731-7895
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Pediatric Department of Mount Sinai

New York, New York

See all 3 affiliations

Find Amanda Agyemang's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Amanda Agyemang is a pediatric allergy/immunology physician in New York, New York

Amanda Agyemang practices at Pediatric Department of Mount Sinai in New York, New York.

Amanda Agyemang's NPI, 1851718043, was assigned on March 25, 2014. Amanda Agyemang holds New York license 289183.

NPI and contact details
NPI enumeration date
March 25, 2014
NPI status
Active
Practice phone
(212) 731-7895
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Female

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Practice Data

Amanda Agyemang practices at Pediatric Department of Mount Sinai in New York, New York

Amanda Agyemang's primary practice is Pediatric Department of Mount Sinai, at 1184 5th Ave, New York, NY 10029 in New York County. The practice phone is (212) 731-7895.

  • Pediatric Department of Mount Sinai
    1184 5th Ave, New York, NY 10029 · New York CountyPhone(212) 731-7895

Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data

Amanda Agyemang is affiliated with 2 sites of care and 1 medical group

Amanda Agyemang's primary practice is Pediatric Department of Mount Sinai in New York, New York. Dmand AI also links Amanda Agyemang to 1 group practice or clinic and 1 medical group, each named with a free account.

Pediatric Department of Mount SinaiNew York, New YorkPrimary
1 group practice or clinicName with a free account1 medical groupName with a free account
See all 3 affiliations for Amanda Agyemang

Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data

Dmand AI tracks the EHR system at Amanda Agyemang's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Amanda Agyemang practices. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Pediatric Department of Mount SinaiAvailable with a free account
+1 more site and 1 medical groupAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Amanda Agyemang practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Amanda Agyemang is one of 40 pediatric allergy/immunology physicians in New York

Pediatric allergy/immunology is Amanda Agyemang's primary specialty in the NPI Registry, under taxonomy code 2080P0201X. Amanda Agyemang is licensed in New York.

Specialties and state licenses

  • Pediatric allergy/immunology, New YorkPrimaryLicense 289183 · taxonomy 2080P0201X

Pediatric allergy/immunology physicians near Amanda Agyemang

Counts of pediatric allergy/immunology physicians with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Amanda Agyemang's patients have a median age of 8

Across all payers, Dmand AI patient panel data puts Amanda Agyemang's median patient age at 8, with 44% women.

Amanda Agyemang's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 8

Patient panel by sex, all payers

  • Women44%
  • Men55%

Source: Dmand AI Patient Panel Data

Amanda Agyemang wrote 26 Medicare Part D claims in 2019

In 2019, Amanda Agyemang wrote 26 Medicare Part D claims. Every claim was for a generic drug. They cover 2 drugs, with $4,598 in total drug cost. In 2018, CMS named 25 claims across 2 drugs.

Part D claims, 201926
Drugs named by CMS2
Total drug cost$4,598

Amanda Agyemang's most prescribed drugs by claims, 2019

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Part D claims for drugs CMS names, 2018 to 2019

  • 2018
  • 2019
Claims for drugs CMS names
2018: 252019: 264%

Drugs named by CMS: 2 in 2019, 2 in 2018.

See all prescribing by Amanda Agyemang

Source: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026

For MedTech and pharma teams

Find pediatric allergy/immunology physicians like Amanda Agyemang by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Amanda Agyemang has 10 publications on record

Dmand AI links 10 papers to Amanda Agyemang, published from 2017 to 2024. 2019 was the busiest year, with 2. The most frequent topics are Allergens, Food Hypersensitivity and Immunoglobulin E. Amanda Agyemang has published most often in J Allergy Clin Immunol Pract. Amanda Agyemang's most frequent co-authors are Anna H. Nowak-Wegrzyn, MD, Scott Sicherer, MD and Hugh Sampson, MD.

Papers10
Years published2017 to 2024

Amanda Agyemang's papers by year, 2017 to 2024

Topics Amanda Agyemang writes about most

  • Allergens
  • Food Hypersensitivity
  • Immunoglobulin E

Amanda Agyemang's most frequent co-authors

Recent publications by Amanda Agyemang

See all 10 publications and co-authors

See who Amanda Agyemang researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Amanda Agyemang works with, so you can find a warm path to the right pediatric allergy/immunology physicians.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Amanda Agyemang received $323 in industry payments from 2019 to 2025

CMS Open Payments shows 6 general payments to Amanda Agyemang from 3 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 100% of the total. ARS Pharmaceuticals Operations, Inc. paid the most, $154.

General payments to Amanda Agyemang by program year, 2019 to 2025

Companies that paid Amanda Agyemang the most, 2019 to 2025

Share is of all general payments to this clinician.

See all payments to Amanda Agyemang

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Sources for Amanda Agyemang's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data
Primary practice, affiliations and health systemNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data
Medicare patients and the all-payer patient panelDmand AI Patient Panel Data
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Industry paymentsOpen Payments (CMS) (opens in a new tab)
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Amanda Agyemang

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Amanda Agyemang's NPI number?

Amanda Agyemang's NPI number is 1851718043. It was assigned on March 25, 2014, and it is active in the NPI Registry.

What does Amanda Agyemang specialize in?

Amanda Agyemang is a pediatric allergy/immunology physician in New York, New York. The primary specialty in the NPI Registry is Pediatric Allergy/Immunology Physician (taxonomy code 2080P0201X).

Where does Amanda Agyemang practice?

Amanda Agyemang practices at 1184 5th Ave, New York, NY 10029. Amanda Agyemang's primary practice is Pediatric Department of Mount Sinai in New York, New York. Dmand AI also links Amanda Agyemang to 1 group practice or clinic and 1 medical group.

What is Amanda Agyemang's office phone number?

The practice phone on file for Amanda Agyemang is (212) 731-7895.

What is Amanda Agyemang's medical license number?

Amanda Agyemang holds New York license 289183.

What drugs does Amanda Agyemang prescribe most?

In 2019 Medicare Part D data, Amanda Agyemang's most prescribed drugs by claims were Epinephrine and Fluticasone Propionate.

Has Amanda Agyemang received payments from drug or device companies?

CMS Open Payments shows $323 in general payments to Amanda Agyemang from 3 companies from 2019 to 2025. The largest total came from ARS Pharmaceuticals Operations, Inc.

How long has Amanda Agyemang been practicing?

Amanda Agyemang's NPI was assigned in 2014.

Does Amanda Agyemang do research?

Dmand AI links 10 publications to Amanda Agyemang, published from 2017 to 2024.

Who does Amanda Agyemang publish with?

Amanda Agyemang's most frequent co-authors are Anna H. Nowak-Wegrzyn, MD (4 shared papers), Scott Sicherer, MD (4 shared papers) and Hugh Sampson, MD (3 shared papers).

Selling to pediatric allergy/immunology practices?

See pediatric allergy/immunology physicians in New York by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)